ÿþ<HTML><HEAD><TITLE>25º Congresso Brasileiro de Microbiologia </TITLE><link rel=STYLESHEET type=text/css href=css.css></HEAD><BODY aLink=#ff0000 bgColor=#FFFFFF leftMargin=0 link=#000000 text=#000000 topMargin=0 vLink=#000000 marginheight=0 marginwidth=0><table align=center width=700 cellpadding=0 cellspacing=0><tr><td align=left bgcolor=#cccccc valign=top width=550><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=3><font size=1>25º Congresso Brasileiro de Microbiologia </font></font></strong><font face=Verdana size=1><b><br></b></font><font face=Verdana, Arial,Helvetica, sans-serif size=1><strong> </strong></font></font></td><td align=right bgcolor=#cccccc valign=top width=150><font face=arial size=2><strong><font face=Verdana, Arial, Helvetica, sans-serif size=1><font size=1>ResumoID:630-1</font></em></font></strong></font></td></tr><tr><td colspan=2><br><br><table align=center width=700><tr><td>Área: <b>Micologia Médica ( Divisão B )</b><p align=justify><strong>ACTION OF ORGANOSULFUR RUTHENIUM AS INHIBITOR OF <EM>CANDIDA</EM> SPP. ADHESION TO HUMAN BUCCAL EPITHELIAL CELLS</strong></p><p align=justify><b>Luciano José Nogueira </b> (<i>UFMG</i>); <b>Claudio Luis Donnici </b> (<i>UFMG</i>); <b><u>Thaís Furtado Ferreira Magalhães </u></b> (<i>UFMG</i>); <b>Maria Aparecida de Resende </b> (<i>UFMG</i>); <b>Cleide Viviane Buzanello Martins </b> (<i>UFMG</i>)<br><br></p><b><font size=2>Resumo</font></b><p align=justify class=tres><font size=2><P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri>Various <I style="mso-bidi-font-style: normal">in vitro</I> studies and animal studies have provided evidence for a relationship between the proclivity of opportunistic<I style="mso-bidi-font-style: normal"> Candida</I> species to adhere to mucosal surfaces (vascular structures such as endothelial cells and subendothelial basement membrane) and their presence in infections. Therefore candidal adherence to human buccal epithelial cells (BECs) is considered as the critical initial step in the pathogenesis of oral candidiasis, which may lead to eventual systemic infection, especially in compromised people. Facing of candidiasis increased, the discovery of new antifungal agents thus remains an important challenge for the scientific community and metal-based drugs might represent an alternative therapeutic route. <?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /><o:p></o:p></FONT></SPAN></P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri>The present work reports the results of inhibition of the adhesion of <I style="mso-bidi-font-style: normal">Candida</I> spp. to BECs by two new antifungal agents (ruthenium dithiocarbamate complexes).<o:p></o:p></FONT></SPAN></P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri>The adhesion testing was performed in accordance with method described by literature and it was tested against four <I style="mso-bidi-font-style: normal">Candida</I> species (<I style="mso-bidi-font-style: normal">C. albicans</I>, <I style="mso-bidi-font-style: normal">C. parapsilosis</I>, <I style="mso-bidi-font-style: normal">C. tropicalis</I> and two clinical isolates strains of <I style="mso-bidi-font-style: normal">C. dubliniensis</I>). Fluconazole (FLC) was used as control. The effect of antifungal drugs on candidal adhesion to BECs has been examined following limited exposure (1h) of the isolates to sublethal concentration of the drug. The preparations of BEC were air dried, fixed with heat and stained with gentian violet. The number of adherent yeast cells was quantified by light microscopy at 400 magnification. In each experiment, 50 BECs were observed for adherent yeast cells. Clumped, folded, or overlapping BECs were excluded.<o:p></o:p></FONT></SPAN></P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><FONT face=Calibri><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US>The reference concentration of testing was obtaining by the determination of the Minimum Inhibitory Concentration (MIC). Compared with the fluconazole, one expressive reduction of adhesion to BECs was observed, was higher for Complex 1 against <I style="mso-bidi-font-style: normal">C. parapsilosis</I> (35%) and Complex 2 against <I style="mso-bidi-font-style: normal">C. tropicallis </I>(25%). By relationship ligand/complex there were data similar in all testing (50%). Others results showed adhesion inhibition as good as fluconazole (ligand 1 agaisnt <I style="mso-bidi-font-style: normal">C. albicans</I> and <I style="mso-bidi-font-style: normal">C. dubliniensis</I> CD22; ligand 2 against <I style="mso-bidi-font-style: normal">C. tropicalis</I> and both <I style="mso-bidi-font-style: normal">C. dubliniensis</I> clinical isolates; complex 1 against <I style="mso-bidi-font-style: normal">C. albicans</I> and <I style="mso-bidi-font-style: normal">C. tropicalis</I>; complex 2 against <I style="mso-bidi-font-style: normal">C. dubliniensis</I> CD22).</SPAN><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-bidi-font-family: Calibri; mso-ansi-language: EN-US" lang=EN-US><o:p></o:p></SPAN></FONT></P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri>In conclusion, inhibition of <I>Candida</I> spp. adhesion by ruthenium dithiocarbamate complexes is clearly epithelial cell-specific for preponderance of strains. Therefore, the presence of drug during the "adherence phase" may be of clinical relevance. These results addition others publications (Minimum Inhibitory Concentration from 10<SUP> 6</SUP>-10<SUP> 8</SUP> micromol.mL<SUP> 1</SUP> against some important fungal pathogens) proved the possible application of these ruthenium complexes as new drugs for invasive fungal infections .</FONT></SPAN></P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri></FONT></SPAN>&nbsp;</P> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt" class=MsoNormal><SPAN style="COLOR: black; FONT-SIZE: 12pt; mso-ansi-language: EN-US" lang=EN-US><FONT face=Calibri><o:p></o:p></FONT></SPAN>&nbsp;</P></font></p><br><b>Palavras-chave: </b>&nbsp;ADESÃO, CANDIDA, MIC</td></tr></table></tr></td></table></body></html>